
October 2025 Digital Pathology Roundup
Dec 1, 2025 - 0:12:56
Radio and PodcastLive Radio & Podcasts
Digital Pathology Roundup – September 2025 Funding: Cyted Health raised €44m Series B led by EQT Life Sciences with Advent Life Sciences and British Business Bank; existing investors Morningside and BGF joined. Funds wil...
September 2025 Digital Pathology Roundup is an episode from Digital-Pathology-Today by Magpie Communications. Digital Pathology Roundup – September 2025 Funding: Cyted Health raised €44m Series B led by EQT Life Sciences with Advent Life Sc...
This episode belongs to Digital-Pathology-Today.
Use the player on this page to stream the episode online.
Published Nov 1, 2025, 0:12:55 long, audio available.
Digital Pathology Roundup – September 2025 Funding: Cyted Health raised €44m Series B led by EQT Life Sciences with Advent Life Sciences and British Business Bank; existing investors Morningside and BGF joined. Funds will drive US expansion, strengthen UK commercialization, and broaden tests beyond EndoSign, its minimally invasive oesophageal cell collection paired with advanced biomarker assays. StratifAI closed €12.5m led by Picus Capital with Alven and others to clinically validate Polaris, a multimodal AI platform that fuses H&E histology, RNA-seq, and outcomes to generate prognostic and predictive spatial insights. Regulatory Approvals: Aiforia obtained CE-IVD for an AI tool detecting lymph node metastases, developed with University of Bern; the company claims up to 40% time savings in cancer staging. Primaa secured CE-IVDR for Cleo Breast, automating biomarker detection on biopsy and surgical specimens and reporting ~15% faster diagnostics; approval enables wider EU deployment and FDA preparation. Ibex earned CE-IVDR for HER2 IHC scoring within its Breast suite, developed with AstraZeneca and Daiichi Sankyo; the suite recognizes 54 breast tissue morphologies. Partnerships and Product Moves: Lunit partnered with Leica Biosystems to place its SCOPR PD-L1 tool in the Aperio AI Store; teamed with Agilent to co-develop AI-powered CDx solutions; and joined CellCarta to offer its pathology AI within CRO clinical trials workflows. Proscia launched Aperture to turn routine diagnostic data into real-time insights for biomarker validation, CDx development, and submissions; it also enhanced Concentriq AP for cytology and partnered with Datexim to add cytology AI. PathAI integrated Mindpeak’s 11 CE-IVD breast and lung tools (plus RUO assays), Stratipath’s CE-IVD prognostic breast model, and Primaa’s CE-IVDR breast and RUO dermpath tools into AISight Dx, further enlarging its CE-IVD ecosystem.
You can listen to September 2025 Digital Pathology Roundup online on Radio and Podcast. Open the player on this page to stream the available audio.
September 2025 Digital Pathology Roundup is an episode from Digital-Pathology-Today by Magpie Communications.
This episode is 0:12:55 long.
This episode was published on Nov 1, 2025.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from Digital-Pathology-Today when more episodes are available from the podcast feed.
You can listen to September 2025 Digital Pathology Roundup on this page when the episode audio is available from the podcast feed.
September 2025 Digital Pathology Roundup is from Digital-Pathology-Today by Magpie Communications.
Published Nov 1, 2025 and 0:12:55 long